Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

RIVIERA MEDICAL CORPORATION

NPI: 1225224389 · NEWPORT BEACH, CA 92660 · Urgent Care Clinic/Center · NPI assigned 09/21/2007

$1.23M
Total Medicaid Paid
54,981
Total Claims
35,758
Beneficiaries
18
Codes Billed
2020-07
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDOONAN, BRYAN (PRESIDENT)
NPI Enumeration Date09/21/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 708 $16K
2021 17,251 $484K
2022 12,576 $294K
2023 6,671 $107K
2024 17,775 $326K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 10,962 4,641 $322K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 9,498 7,786 $267K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 5,123 5,035 $157K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 7,640 6,581 $147K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,094 4,919 $123K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 12,672 4,700 $97K
87631 1,121 560 $50K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 216 188 $23K
86328 332 323 $13K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 882 597 $12K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 176 176 $8K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 56 55 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 33 32 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 66 66 $1K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 24 24 $982.08
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 33 33 $386.16
99307 24 13 $328.80
99072 29 29 $0.00